INTERNATIONAL PATENT: BISIRNA THERAPEUTICS (SUZHOU) CO., LTD., 倍臻生物技术（苏州）有限公司 FILES APPLICATION FOR "MODIFIED DOUBLE-STRANDED RIBONUCLEIC ACID AND USE THEREOF"

Posted On: 2026-03-09

GENEVA, March 9 -- BISIRNA THERAPEUTICS (SUZHOU) CO., LTD. (Unit 401, Building 5, Block B, Phase III, Biomedical Industrial Park, No. 99 Jingu RoadSuzhou, Jiangsu 215000), 倍臻生物技术（苏州）有限公司 (中国江苏省苏州市中国（江苏）自由贸易试验区苏州片区苏州工业园区金谷路99号生物医药产业园三期B区5号楼401单元) filed a patent application (PCT/CN2025/116909) for "MODIFIED DO...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

INTERNATIONAL PATENT: BISIRNA THERAPEUTICS (SUZHOU) CO., LTD., 倍臻生物技术（苏州）有限公司 FILES APPLICATION FOR "MODIFIED DOUBLE-STRANDED RIBONUCLEIC ACID AND USE THEREOF"